When dose reduction is appropriate Phase 3 trials include provisions for dose reduction: Gastrointestinal adverse events or inadequate oral intake may warrant stepping down to a lower dose level see Retatrutide Side Effects for incidence rates by dose BMI reaching 22 kg/m or below , or perceived excessive weight loss, allows dose reduction Treatment is discontinued at BMI 18.5 kg/m or below How Often and When to Take Retatrutide Injection frequency once weekly by subcutaneous injection, on the same day each week
Shot History A full log of every injection, so you always have a record
Because retatrutide is not licensed in the UK, it cannot be legally prescribed, dispensed, or sold through standard NHS or private pharmacy channels
Similarly, a case series of four patients treated with exenatide reported improved glucose control and HbA1c after four months of therapy (40)
GLP-1 has a beneficial impact on metabolism, including the reduction of appetite and weight gain, and improves blood glucose control, adds Gerdes in that same column
For advanced outcomes, rotate with Tesamorelin + Ipamorelin + AOD-9604 + MOTS-C to support both fat metabolism and mitochondrial function.